Drug Profile
Research programme: influenza therapeutics - adMare BioInnovations/University of Sherbrooke
Alternative Names: NEO 8877Latest Information Update: 07 Oct 2020
Price :
$50
*
At a glance
- Originator Institut de pharmacologie de Sherbrooke; NEOMED; University of Sherbrooke
- Class Antivirals
- Mechanism of Action Serine protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Influenza-virus-infections in Canada (Inhalation)
- 26 Sep 2013 Early research in Influenza virus infections in Canada (unspecified route)